214 related articles for article (PubMed ID: 17018653)
21. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
22. No evidence of RET germline mutations in familial pituitary adenoma.
Heliövaara E; Tuupanen S; Ahlsten M; Hodgson S; de Menis E; Kuismin O; Izatt L; McKinlay Gardner RJ; Gundogdu S; Lucassen A; Arola J; Tuomisto A; Mäkinen M; Karhu A; Aaltonen LA
J Mol Endocrinol; 2011 Feb; 46(1):1-8. PubMed ID: 20956458
[TBL] [Abstract][Full Text] [Related]
23. Screening of
Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
[No Abstract] [Full Text] [Related]
24. Familial pituitary adenomas - who should be tested for AIP mutations?
Korbonits M; Storr H; Kumar AV
Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
[TBL] [Abstract][Full Text] [Related]
26. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
[TBL] [Abstract][Full Text] [Related]
28. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
29. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
30. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S; Ogret YD; Oguz FS
Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
[TBL] [Abstract][Full Text] [Related]
31. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
32. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
34. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
35. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
[TBL] [Abstract][Full Text] [Related]
36. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
Lloyd C; Grossman A
Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639
[TBL] [Abstract][Full Text] [Related]
37. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
[TBL] [Abstract][Full Text] [Related]
38.
Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
Tichomirowa MA; Barlier A; Daly AF; Jaffrain-Rea ML; Ronchi C; Yaneva M; Urban JD; Petrossians P; Elenkova A; Tabarin A; Desailloud R; Maiter D; Schürmeyer T; Cozzi R; Theodoropoulou M; Sievers C; Bernabeu I; Naves LA; Chabre O; Montañana CF; Hana V; Halaby G; Delemer B; Aizpún JI; Sonnet E; Longás AF; Hagelstein MT; Caron P; Stalla GK; Bours V; Zacharieva S; Spada A; Brue T; Beckers A
Eur J Endocrinol; 2011 Oct; 165(4):509-15. PubMed ID: 21753072
[TBL] [Abstract][Full Text] [Related]
40. The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?
Occhi G; Jaffrain-Rea ML; Trivellin G; Albiger N; Ceccato F; De Menis E; Angelini M; Ferasin S; Beckers A; Mantero F; Scaroni C
J Endocrinol Invest; 2010 Dec; 33(11):800-5. PubMed ID: 20354355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]